aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet [Gaviscon Chewable]
RxNorm concept 1086458, branded drug (sbd). Prescribable name: Gavsicon Regular Strength 80 MG / 14.2 MG Chewable Tablet.
- RxCUI
- 1086458
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1086458 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Gaviscon Chewable 80/14.2 (aluminum hydroxide / magnesium trisilicate) Chewable Tablet; Gaviscon Chewable 80/14.2 Chewable Tablet; Gavsicon Regular Strength (aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG) Chewable Tablet
Related concepts
- aluminum hydroxide 80 MG (SCDC, consists of)
- magnesium trisilicate 14.2 MG (SCDC, consists of)
- aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG [Gaviscon Chewable] (SBDC, consists of)
- Chewable Tablet (DF, has dose form)
- Gaviscon Chewable (BN, has ingredient)
- aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet (SCD, tradename of)
Linked data
NDCs
- 00135009626
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1086458 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1086458 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1086458. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.